Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Nasi

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Biomedicines|February 25, 2023
A New Insight into MYC Action: Control of RNA Polymerase II Methylation and Transcription TerminationFiorella Scagnoli, Alessandro Palma, Annarita Favia, et al.
Plos One|August 4, 2011
The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapyMauro Savino, Daniela Annibali, Nicoletta Carucci, et al.
Oncotarget|March 7, 2018
Copper/MYC/CTR1 interplay: a dangerous relationship in hepatocellular carcinomaCristiana Porcu, Laura Antonucci, Barbara Barbaro, et al.
FEBS Letters|January 5, 2002
NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interactionGeorgia Mandolesi, Silvia Gargano, Maria Pennuto, et al.
Oncotarget|April 28, 2016
c-MYC inhibition impairs hypoxia response in glioblastoma multiformeMaria Patrizia Mongiardi, Mauro Savino, Maria Laura Falchetti, et al.
Neuromolecular Medicine|February 5, 2014
MiR-21 is an Ngf-modulated microRNA that supports Ngf signaling and regulates neuronal degeneration in PC12 cellsEnrica Montalban, Nicola Mattugini, Roberta Ciarapica, et al.
Scientific Reports|November 6, 2019
The Protein Arginine Methyltransferases 1 and 5 affect Myc properties in glioblastoma stem cellsAnnarita Favia, Luisa Salvatori, Simona Nanni, et al.
Scientific Reports|November 14, 2015
Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cellsMaria Patrizia Mongiardi, Mauro Savino, Laura Bartoli, et al.
Nature|August 22, 2008
Modelling Myc inhibition as a cancer therapyLaura Soucek, Jonathan Whitfield, Carla P Martins, et al.
American Journal of Clinical Pathology|August 23, 2012
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastomaTonia Cenci, Maurizio Martini, Nicola Montano, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Biomedicines|February 25, 2023
A New Insight into MYC Action: Control of RNA Polymerase II Methylation and Transcription TerminationFiorella Scagnoli, Alessandro Palma, Annarita Favia, et al.
Plos One|August 4, 2011
The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapyMauro Savino, Daniela Annibali, Nicoletta Carucci, et al.
Oncotarget|March 7, 2018
Copper/MYC/CTR1 interplay: a dangerous relationship in hepatocellular carcinomaCristiana Porcu, Laura Antonucci, Barbara Barbaro, et al.
FEBS Letters|January 5, 2002
NGF-dependent and tissue-specific transcription of vgf is regulated by a CREB-p300 and bHLH factor interactionGeorgia Mandolesi, Silvia Gargano, Maria Pennuto, et al.
Oncotarget|April 28, 2016
c-MYC inhibition impairs hypoxia response in glioblastoma multiformeMaria Patrizia Mongiardi, Mauro Savino, Maria Laura Falchetti, et al.
Neuromolecular Medicine|February 5, 2014
MiR-21 is an Ngf-modulated microRNA that supports Ngf signaling and regulates neuronal degeneration in PC12 cellsEnrica Montalban, Nicola Mattugini, Roberta Ciarapica, et al.
Scientific Reports|November 6, 2019
The Protein Arginine Methyltransferases 1 and 5 affect Myc properties in glioblastoma stem cellsAnnarita Favia, Luisa Salvatori, Simona Nanni, et al.
Scientific Reports|November 14, 2015
Myc and Omomyc functionally associate with the Protein Arginine Methyltransferase 5 (PRMT5) in glioblastoma cellsMaria Patrizia Mongiardi, Mauro Savino, Laura Bartoli, et al.
Nature|August 22, 2008
Modelling Myc inhibition as a cancer therapyLaura Soucek, Jonathan Whitfield, Carla P Martins, et al.
American Journal of Clinical Pathology|August 23, 2012
Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastomaTonia Cenci, Maurizio Martini, Nicola Montano, et al.
Pageof 3